Tg(KRT5-cre/ERT2)AJdg
Transgene Detail
|
|
| Symbol: |
Tg(KRT5-cre/ERT2)AJdg |
| Name: |
transgene insertion A, John DiGiovanni |
| MGI ID: |
MGI:3807716 |
| Transgene: |
Tg(KRT5-cre/ERT2)AJdg Location: unknown
|
| Alliance: |
Tg(KRT5-cre/ERT2)AJdg page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
| Inducer: |
|
tamoxifen |
| Mutation: |
|
Insertion
|
| |
|
Tg(KRT5-cre/ERT2)AJdg expression driven by
1 gene
Transgene expression driven by:
| Organism |
Driver Gene |
Note |
| cattle |
KRT5 (281268) |
|
|
| |
|
Mutation details: A DNA construct composed cre sequence and the human tamoxifen responsive estrogen receptor ligand-binding domain (ERT2 was placed under the control of the bovine KRT5 promoter. Three founder lines were produced. Line A showed the highest inducible cre expression.
(J:138529)
|
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
|
Driver:
|
KRT5
(cattle)
|
| |
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:138529 Kataoka K, et al., Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis. 2008 Jun;29(6):1108-14 |
| All: |
7 reference(s) |
|
Analysis Tools
